Publicaciones en las que colabora con David Navarro Ortega (14)

2024

  1. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

2023

  1. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  2. Dynamics of Human Anelloviruses in Plasma and Clinical Outcomes Following Kidney Transplantation

    Transplantation, Vol. 107, Núm. 2, pp. 511-520

2022

  1. Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates

    Transplant Infectious Disease, Vol. 24, Núm. 1

  2. Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation

    Frontiers in Genetics, Vol. 13

2021

  1. SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19

    Transplantation, Vol. 105, Núm. 6, pp. 1372-1380

2020

  1. A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score

    The Journal of infectious diseases, Vol. 222, Núm. 3, pp. 479-487

  2. Early kinetics of Torque Teno virus DNA load and BK polyomavirus viremia after kidney transplantation

    Transplant Infectious Disease

2019

  1. Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation

    American Journal of Transplantation, Vol. 19, Núm. 4, pp. 1139-1149

  2. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment

    Clinical Microbiology and Infection, Vol. 25, Núm. 3, pp. 381.e1-381.e10

2015

  1. Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    Journal of Infection, Vol. 71, Núm. 5, pp. 561-570

  2. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646

  3. Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity among CMV-Seropositive Kidney Transplant Candidates

    American Journal of Transplantation

2013

  1. Epstein-barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients

    Transplantation, Vol. 95, Núm. 5, pp. 688-693